STRO
Sutro Biopharma
NASDAQ: STRO · HEALTHCARE · BIOTECHNOLOGY
$35.39
+2.02% today
Updated 2026-04-29
Market cap
$556.51M
P/E ratio
—
P/S ratio
5.43x
EPS (TTM)
$-22.49
Dividend yield
—
52W range
$7 – $36
Volume
0.2M
Sutro Biopharma (STRO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $59.73M | $51.74M | $38.42M | $42.74M | $42.72M | $61.88M | $67.77M | $153.73M | $62.04M | $102.48M |
| Revenue growth (YoY) | — | -13.4% | -25.7% | +11.2% | -0.0% | +44.8% | +9.5% | +126.8% | -59.6% | +65.2% |
| Cost of revenue | $43.55M | $51.90M | $54.26M | $65.61M | $76.96M | $9.77M | $8.29M | $6.82M | $7.22M | $7.32M |
| Gross profit | $16.18M | $-156000.00 | $-15.84M | $42.74M | $-34.24M | $52.11M | $59.48M | $146.91M | $54.83M | $95.16M |
| Gross margin | 27.1% | -0.3% | -41.2% | 100.0% | -80.1% | 84.2% | 87.8% | 95.6% | 88.4% | 92.9% |
| R&D | $43.55M | $54.64M | $54.26M | $65.61M | $76.96M | $104.40M | $137.17M | $180.43M | $252.04M | $166.42M |
| SG&A | $14.82M | $16.37M | $21.38M | $32.59M | $36.82M | $56.00M | $59.54M | $62.58M | $48.45M | $41.02M |
| Operating income | $1.36M | $-19.27M | $-37.22M | $-55.47M | $-71.06M | $-98.52M | $-128.94M | $-89.28M | $-238.45M | $-104.95M |
| Operating margin | 2.3% | -37.2% | -96.9% | -129.8% | -166.3% | -159.2% | -190.3% | -58.1% | -384.3% | -102.4% |
| EBITDA | $7.36M | $-14.09M | $-32.82M | $-46.62M | $-23.75M | $-97.56M | $-105.07M | $-67.92M | $-180.45M | $-97.63M |
| EBITDA margin | 12.3% | -27.2% | -85.4% | -109.1% | -55.6% | -157.7% | -155.0% | -44.2% | -290.9% | -95.3% |
| EBIT | $1.70M | $-19.08M | $-37.36M | $-51.39M | $-28.05M | $-102.40M | $-113.36M | $-74.73M | $-187.67M | $-104.95M |
| Interest expense | $0.00 | $689000.00 | $1.60M | $4.35M | $3.97M | $3.14M | $3.35M | $23.75M | $31.07M | $38.21M |
| Income tax | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $1.70M | $-19.69M | $-35.32M | $-55.74M | $-32.13M | $-105.54M | $-119.20M | $-106.79M | $-227.46M | $-191.09M |
| Net income growth (YoY) | — | -1256.8% | -79.4% | -57.8% | +42.4% | -228.5% | -12.9% | +10.4% | -113.0% | +16.0% |
| Profit margin | 2.8% | -38.1% | -91.9% | -130.4% | -75.2% | -170.6% | -175.9% | -69.5% | -366.6% | -186.5% |